Literature DB >> 9361181

Prevalence and incidence of gallstones in liver cirrhosis.

J A Del Olmo1, F García, M A Serra, L Maldonado, J M Rodrigo.   

Abstract

BACKGROUND: Our aim was to assess the prevalence and incidence of gallstone disease in patients with liver cirrhosis and to identify risk factors for cholecystolithiasis.
METHODS: We studied a cohort of 313 patients with liver cirrhosis confirmed by histology and/or laparoscopy and 357 patients free of liver disease, who had been referred for ultrasonographic examination of the upper abdomen. Hepatobiliary ultrasonography was performed when liver cirrhosis was diagnosed and every 6 months thereafter. Risk factors for cholelithiasis (age, gender, diet, pregnancy, diabetes, family history of cholelithiasis, etiology of cirrhosis, decompensated disease) were assessed.
RESULTS: The overall prevalence of gallstones in cirrhotic patients was 23.3%. In controls, the overall prevalence of cholecystolithiasis was 16.8%. After a median follow-up period of 65 months, 30 patients developed gallstones. The calculated annual incidence was 3.4%.
CONCLUSIONS: Given that the prevalence of gallstone disease is higher in cirrhotics than in noncirrhotic patients, cirrhosis of the liver may be considered a risk factor for cholecystolithiasis.

Entities:  

Mesh:

Year:  1997        PMID: 9361181     DOI: 10.3109/00365529709011225

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  14 in total

1.  Clinical correlation of gallstone disease in a Chinese population in Taiwan: experience at Cheng Hsin General Hospital.

Authors:  Chi-Ming Liu; Tao-Hsin Tung; Pesus Chou; Victor Tze-Kai Chen; Chung-Te Hsu; Wu-Shyong Chien; Yeu-Tyng Lin; Hsu-Feng Lu; Hui-Chuan Shih; Jorn-Hon Liu
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

2.  Endoscopic treatment of biliary tract disease prior to orthotopic liver transplantation.

Authors:  Roshan Shrestha; David M S Grunkemeier
Journal:  Curr Treat Options Gastroenterol       Date:  2006-04

3.  A population-based follow-up study on gallstone disease among type 2 diabetics in Kinmen, Taiwan.

Authors:  Tao-Hsin Tung; Hsiao-Man Ho; Hui-Chuan Shih; Pesus Chou; Jorn-Hon Liu; Victor-T K Chen; De-Chuan Chan; Chi-Ming Liu
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

4.  National trends of endoscopic retrograde cholangiopancreatography utilization and outcomes in decompensated cirrhosis.

Authors:  Dhruv Mehta; Priti Poojary; Aparna Saha; Supreet Kaur; Shanti Patel; Lavneet Chawla; Arun Kumar; Priya Simoes; Deepthi Busayavalasa; Girish Nadkarni; Madhusudhan Sanaka
Journal:  Surg Endosc       Date:  2018-06-25       Impact factor: 4.584

5.  Choledocholithiasis in the Setting of Portal Hypertension.

Authors:  Yajaira Sierra; Irving Waxman
Journal:  Curr Treat Options Gastroenterol       Date:  2001-04

6.  Autonomic dysfunction and cholelithiasis in patients with cirrhosis.

Authors:  A Chawla; L Puthumana; P J Thuluvath
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

Review 7.  Gallstones in chronic liver disease.

Authors:  Michael Anthony Silva; Terence Wong
Journal:  J Gastrointest Surg       Date:  2005 May-Jun       Impact factor: 3.452

8.  Safety and efficacy of endoscopic retrograde cholangiopancreatography for common bile duct stones in liver cirrhotic patients.

Authors:  De-Min Li; Jie Zhao; Qiu Zhao; Hua Qin; Bo Wang; Rong-Xiang Li; Min Zhang; Ji-Fen Hu; Min Yang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-08-19

9.  Cirrhosis is not a contraindication to laparoscopic cholecystectomy: results and practical recommendations.

Authors:  Kevin Tri Nguyen; Krit Kitisin; Jennifer Steel; Geetha Jeyabalan; Shushma Aggarwal; David A Geller; T Clark Gamblin
Journal:  HPB (Oxford)       Date:  2011-01-25       Impact factor: 3.647

Review 10.  Gallstone Disease in Cirrhosis-Pathogenesis and Management.

Authors:  Bipadabhanjan Mallick; Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2021-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.